|
US8409564B2
(en)
|
1999-10-05 |
2013-04-02 |
Universite De Montreal |
Rhodamine derivatives for photodynamic diagnosis and treatment
|
|
DE60043511D1
(de)
*
|
1999-10-20 |
2010-01-21 |
Chugai Pharmaceutical Co Ltd |
Verwendung von g-csf zur hemmung der gvhd
|
|
AU2001292564A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Emory University |
A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
|
|
US6869956B2
(en)
|
2000-10-03 |
2005-03-22 |
Bristol-Myers Squibb Company |
Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
|
|
EP1361896A2
(en)
*
|
2001-01-23 |
2003-11-19 |
Boston Scientific Corporation |
Localized myocardial injection method for treating ischemic myocardium
|
|
JP2004528021A
(ja)
|
2001-02-14 |
2004-09-16 |
アンスロジェネシス コーポレーション |
分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
|
|
CA2342675A1
(en)
*
|
2001-04-02 |
2002-10-02 |
Abdelkrim Habi |
Halogenated rhodamine derivatives and applications thereof
|
|
WO2003001981A2
(en)
*
|
2001-06-29 |
2003-01-09 |
The Government Of The United State Of America As Represent By The Secretary Of The Department Of Health And Human Services |
Method of promoting engraftment of a donor transplant in a recipient host
|
|
US7037900B2
(en)
*
|
2001-10-12 |
2006-05-02 |
Supergen, Inc. |
Composition and method for treating graft-versus-host disease
|
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
|
NZ579705A
(en)
|
2002-02-13 |
2011-07-29 |
Anthrogenesis Corp |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
CA105900S
(en)
|
2003-08-12 |
2006-10-19 |
180S Inc |
Frame for ear warmer
|
|
JP4901479B2
(ja)
*
|
2003-12-05 |
2012-03-21 |
ユニヴェルシテ ドゥ モントリオール |
免疫疾患、感染症および癌の阻止、保護、予防または治療のための免疫学的化合物
|
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
|
WO2006057951A2
(en)
*
|
2004-11-22 |
2006-06-01 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the treatment of graft failure
|
|
WO2007047978A2
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
JP2009513672A
(ja)
|
2005-10-31 |
2009-04-02 |
ブレインセルス，インコーポレイティド |
神経発生のｇａｂａ受容体媒介調節
|
|
PT2471905T
(pt)
|
2005-12-29 |
2019-01-11 |
Celularity Inc |
Populações de células estaminais placentárias
|
|
AU2006332679A1
(en)
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
MX2008014320A
(es)
|
2006-05-09 |
2009-03-25 |
Braincells Inc |
Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
|
|
EP2377531A2
(en)
|
2006-05-09 |
2011-10-19 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US20090197823A1
(en)
|
2006-05-09 |
2009-08-06 |
Braincells, Inc. |
Aliskiren modulation of neurogenesis
|
|
US7998971B2
(en)
|
2006-09-08 |
2011-08-16 |
Braincells Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CN101631852A
(zh)
|
2006-10-23 |
2010-01-20 |
人类起源公司 |
用胎盘细胞群治疗骨缺损的方法和组合物
|
|
WO2008083204A2
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc. |
Modulation of neurogenesis by melatoninergic ligands
|
|
WO2008086483A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
|
WO2008097861A2
(en)
*
|
2007-02-02 |
2008-08-14 |
Braincells, Inc. |
MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS
|
|
WO2009123877A1
(en)
*
|
2008-03-21 |
2009-10-08 |
Braincells, Inc. |
A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257
|
|
CA2965883C
(en)
|
2008-08-22 |
2020-05-12 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
MX2012011543A
(es)
|
2010-04-08 |
2013-05-06 |
Anthrogenesis Corp |
Tratamiento de sarcoidosis empleando celulas madre placentarias.
|
|
WO2012092485A1
(en)
|
2010-12-31 |
2012-07-05 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory rna molecules
|
|
WO2012166844A2
(en)
|
2011-06-01 |
2012-12-06 |
Anthrogenesis Corporation |
Treatment of pain using placental stem cells
|
|
WO2023277114A1
(ja)
*
|
2021-07-02 |
2023-01-05 |
公益財団法人神戸医療産業都市推進機構 |
放射線照射造血幹細胞を含む医薬組成物
|